Literature DB >> 9124555

Glucose production, recycling, Cori cycle, and gluconeogenesis in humans: relationship to serum cortisol.

J A Tayek1, J Katz.   

Abstract

Six normal subjects (NL group) and 13 cancer patients (CAI and CAII groups) were fasted overnight and infused with [U-(13)C]glucose (0.016-0.058 mg x min(-1) x kg(-1)). Plasma glucose and lactate were isolated, and mass isotopomer distributions were determined by gas chromatography-mass spectroscopy. Applying equations modified from those previously described [J. A. Tayek and J. Katz. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E709-E717, 1996], we determined glucose production (GP), recycling of glucose carbons, fraction of recycled molecules in blood glucose (Cori cycle), formation of pyruvate from unlabeled carbons, dilution of pyruvate via the tricarboxylic acid cycle and other reactions, and rate of gluconeogenesis. Glucose production was similar in all groups: 2.4 +/- 0.2 mg x min(-1) x kg (-1). The fraction of recycled carbon and of the Cori cycle were elevated in the CAI group vs. the CAII and NL groups: 15 and 33% vs. 7.8 and 19%, respectively (P = 0.01). Gluconeogenesis was 1.9 +/- 0.1, 1.0 +/- 0.1, and 0.83 +/- 0.11 mg x min(-1) x kg(-1) in the CAI, CAII, and NL groups, respectively. In the NL and CAII groups, 20% of GP is via recycling, 20% from unlabeled carbon sources (muscle glycogen, amino acids), and 60% from hepatic glycogenolysis; in the CAI group, 30% is from recycling, 50% from unlabeled carbon, and 20% from glycogen and other sources. Serum cortisol was elevated in the CAI group vs. the CAII group: 11.2 +/- 1.2 vs. 7.7 +/- 1.2 microg/dl (P < 0.05). There was a strong correlation between plasma cortisol and Cori cycle in the NL (r = 0.963) and CAI and CAII groups (r = 0.771). Serum cortisol was directly, and insulin was inversely, correlated with gluconeogenesis in the NL (r2 = 0.967) and CAI and CAII groups (r2 = 0.727). We conclude that whereas the cancer population is heterogeneous with respect to gluconeogenesis, many cancer patients derive their GP predominantly from gluconeogenesis compared with healthy controls, who derive less than one-half of their GP from gluconeogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124555     DOI: 10.1152/ajpendo.1997.272.3.E476

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  Evaluation of regression models in metabolic physiology: predicting fluxes from isotopic data without knowledge of the pathway.

Authors:  Maciek R Antoniewicz; Gregory Stephanopoulos; Joanne K Kelleher
Journal:  Metabolomics       Date:  2006-05-20       Impact factor: 4.290

3.  Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.

Authors:  Madhu N Rao; Kathleen Mulligan; Viva Tai; Michael J Wen; Artem Dyachenko; Melissa Weinberg; Xiaojuan Li; Thomas Lang; Carl Grunfeld; Jean-Marc Schwarz; Morris Schambelan
Journal:  J Clin Endocrinol Metab       Date:  2010-07-07       Impact factor: 5.958

4.  Gluconeogenesis is not regulated by either glucose or insulin in extremely low birth weight infants receiving total parenteral nutrition.

Authors:  Shaji K Chacko; Jorge Ordonez; Pieter J J Sauer; Agneta L Sunehag
Journal:  J Pediatr       Date:  2011-02-15       Impact factor: 4.406

Review 5.  Contemporary Use of Corticosteroids in Rhinology.

Authors:  Alexander Karatzanis; Alkiviadis Chatzidakis; Athanasia Milioni; Stephan Vlaminck; Hideyuki Kawauchi; Stylianos Velegrakis; Emmanuel Prokopakis
Journal:  Curr Allergy Asthma Rep       Date:  2017-02       Impact factor: 4.806

Review 6.  New-onset diabetes after transplantation.

Authors:  Martha Pavlakis
Journal:  Curr Diab Rep       Date:  2005-08       Impact factor: 4.810

Review 7.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

Review 8.  Computational modeling of cancer cachexia.

Authors:  Kevin D Hall; Vickie E Baracos
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-05       Impact factor: 4.294

9.  Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia.

Authors:  Douglas E Friesen; Vickie E Baracos; Jack A Tuszynski
Journal:  Theor Biol Med Model       Date:  2015-09-15       Impact factor: 2.432

10.  The role of glucose metabolism and glucose-associated signalling in cancer.

Authors:  Rainer Wittig; Johannes F Coy
Journal:  Perspect Medicin Chem       Date:  2008-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.